BJDX BLUEJAY DIAGNOSTICS INC Management Changes 8-K Filing 2024 - Termination of Agreement and Annual Meeting Announcement Bluejay Diagnostics terminated an agreement with DLA, resulting in the departure of the Interim CFO and appointment of the CEO as the principal financial officer. They also announced the date and location of their 2024 annual meeting of stockholders.Get access to all SEC 8-K filings of the BLUEJAY DIAGNOSTICS INC